Virtu Financial’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-23,962
Closed -$158K 2116
2021
Q2
$158K Buy
+23,962
New +$167K 0.02% 1073
2021
Q1
Sell
-11,216
Closed -$72K 2168
2020
Q4
$72K Sell
11,216
-62,036
-85% -$362K 0.01% 1149
2020
Q3
$264K Buy
+73,252
New +$296K 0.05% 495
2019
Q4
$352K Buy
69,048
+497
+0.7% +$1.69K 0.03% 594
2019
Q3
$166K Sell
68,551
-16,909
-20% -$44.9K 0.01% 1006
2019
Q2
$185K Buy
85,460
+58,389
+216% +$138K 0.01% 1037
2019
Q1
$73K Buy
+27,071
New +$117K ﹤0.01% 1165
2018
Q3
Sell
-63,430
Closed -$617K 2353
2018
Q2
$617K Sell
63,430
-1,871
-3% -$19.7K 0.04% 672
2018
Q1
$687K Buy
+65,301
New +$645K 0.04% 537
2014
Q4
Sell
-13,660
Closed -$145K 414
2014
Q3
$145K Buy
+13,660
New +$155K 0.02% 278

Other funds holding IMGN

Virtu Financial's IMGN Position: Q3 2021 in Review

Virtu Financial sold out of Immunogen Inc (IMGN) in Q3 2021, closing a stake of 23,962 shares — an estimated $158K sold.

Virtu Financial first reported a position in IMGN in Q3 2014 and held it in 10 quarters. The position peaked at $687K in Q1 2018. 217 funds tracked by Wall St. Rank hold IMGN as of Q3 2021.

  • Virtu Financial reported no remaining Immunogen Inc position as of Q3 2021 after selling out during the quarter.
  • Virtu Financial sold 23,962 Immunogen Inc shares in Q3 2021, an estimated $158K.
  • Virtu Financial first reported a position in Immunogen Inc in Q3 2014 and held it in 10 quarters.
  • Virtu Financial's Immunogen Inc position peaked at $687K in Q1 2018.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2021.

Based on Virtu Financial's 13F filing for Q3 2021, filed 12 Nov 2021.